Contact FICCI
ICMR signs MoU with FICCI for commercialization of technologies for providing affordable healthcare solutions at the last mile
Nov 17, 2017
NEW DELHI, 17 November 2017: The Federation of Indian Chambers of Commerce and Industry
(FICCI) today signed a MOU with Indian Council of Medical Research (ICMR) for
Health Technology Accelerated Commercialization (H:TAC) Program. H:TAC will be
implemented in partnership with the IC2 Institute at the University of Texas at
Austin. Under the program, FICCI and IC2 Institute will
commercialize technologies developed by ICMR labs for the benefit of
communities at large.
The program will leverage the expertise and technical knowledge of
ICMR scientists who have developed much needed affordable healthcare
technologies. The program will ensure market access for the already developed
technologies of ICMR labs and it would accelerate the availability of advanced
diagnosis, treatment, prevention and healthcare delivery, benefitting the
health and welfare of every Indian citizen.
H:TAC will also build capacities for ICMR scientists by providing
them training on technology commercialization strategies and giving them an
exposure on global best practices on innovation and commercialization. The
program will take innovations from ICMR labs to not only Indian markets but
global markets by providing handholding and business development support to
ICMR scientists.
The MOU was signed in the presence of Dr. Sanjaya Baru, Secretary
General, Federation of Indian Chambers of Commerce & Industry; Dr. Soumya
Swaminathan, Secretary, DHR & Director General, Indian Council of Medical
Research; Dr. Sanjay Madhav Mehendale, Additional Director General ICMR;
Ms. Ritu Dhillon IAAS, Sr. Financial Advisor ICMR; Dr. Chandershekhar,
Scientist G & Head- Innovation & Translational Research, Intellectual
Property Rights, ICMR and other eminent experts of ICMR.
FICCI MEDIA DIVISION